FDA Approved: LUPKYNIS — Original Application (Aurinia Pharma U.S., Inc.)

View source ↗

Summary

FDA approves LUPKYNIS (voclosporin) from Aurinia Pharma U.S., Inc. in an Original Application NDA for the treatment of active lupus nephritis in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• LUPKYNIS (voclosporin)

Snippet

ORIG AP for LUPKYNIS (VOCLOSPORIN)